News

Media And Political Bulletin – 24 September 2018

Media and Political Bulletin

24 September 2018

Media Summary

FMD must not compromise integrity of supply chain or delay passage of medicines to patients, warns CCA

Pharmacy Business, Neil Trainis, 21 September 2018

Pharmacy Business reports that the Company Chemists’ Association has warned that safety features that are due to come in under the Falsified Medicines Directive must ‘not compromise the integrity of the supply chain or delay the passage of medicines to patients.’

From February 9 next year pharmacists will be required to scan the barcodes of all medicines at the point of dispensing and check the anti-tampering device, a regulation that comes into effect just weeks before the UK leaves the European Union on March 29.

In its response to a consultation by the Medicines and Healthcare products Regulatory Agency, the CCA called for ‘a proportionate and risk-based approach to the implementation of the safety features aspect of the Falsified Medicines Directive.’ The body said that it was concerned that pharmacy businesses were having to enter into legal agreements and commit to financial investments in IT, staff training and other areas to the backdrop of uncertainty over how long FMD will be in place given ongoing Brexit negotiations.

Parliamentary Coverage

There was no parliamentary coverage today.

Full Coverage

FMD must not compromise integrity of supply chain or delay passage of medicines to patients, warns CCA

Pharmacy Business, Neil Trainis, 21 September 2018

Safety features that are due to come in under the Falsified Medicines Directive (FMD) must not compromise the integrity of the supply chain or delay the passage of medicines to patients, the Company Chemists’ Association (CCA) has warned.

From February 9 next year pharmacists will be required to scan the barcodes of all medicines at the point of dispensing and check the anti-tampering device, a regulation that comes into effect just weeks before the UK leaves the European Union on March 29.

In its response to a consultation by the Medicines and Healthcare products Regulatory Agency, the CCA called for “a proportionate and risk-based approach to the implementation of the safety features aspect of the Falsified Medicines Directive.”

“This is in order that patient safety and integrity of the supply-chain can be assured, while not undermining the efficiency and cost-effectiveness of dispensing in community pharmacy,” the CCA said.

The body said it was concerned that pharmacy businesses were having to enter into legal agreements and commit to financial investments in IT, staff training and other areas to the backdrop of uncertainty over how long FMD will be in place given ongoing Brexit negotiations.

CCA chief executive Malcolm Harrison said: “Our priority for FMD is to ensure patient safety and integrity of the supply chain are maintained as the UK leaves the EU, while not undermining the efficiency and cost-effectiveness of dispensing in community pharmacy.

“Our members are all working hard to ensure they will be compliant with FMD once it takes effect in February.”

He added: “We agree with the FMD Working Group that the government must be open and transparent with the pharmacy sector. This is to ensure that community pharmacy, which is already financially challenged, is not required to invest in FMD systems if they will not be needed in the future.

“If community pharmacies remain required to comply with these new aspects of the Directive, we believe the additional cost burden should be taken into account within any new NHS funding settlement.

“In the event of the UK medicines verification system being disconnected from the European hub after Brexit, we similarly agree with the FMD Working Group that the government should fully compensate the sector, where all or part of the system which has been invested in becomes redundant.”

Media And Political Bulletin – 24 September 2018

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?